Zhang Shuchen, Wang Wenjing, Wu Xiaoguang, Zhou Xiang
Department of Cardiology, The Second Affiliated Hospital of Soochow University, Suzhou 215004, P.R. China.
Department of Cardiology, The Second Affiliated Hospital of Soochow University, Suzhou 215004, P.R. China.
Mol Ther Nucleic Acids. 2020 Sep 4;21:172-179. doi: 10.1016/j.omtn.2020.05.024. Epub 2020 May 23.
Coronary artery disease (CAD) is a cardiac disorder caused by abnormal structure or function of the coronary artery, which leads to myocardial ischemia and hypoxia. CAD is a major cause of morbidity and mortality worldwide. Although there are currently effective drug therapies, there is a pressing need to find novel molecular therapeutic targets for CAD. The development of molecular biology technology has allowed the recognition of circular RNAs (circRNAs) as a novel class of noncoding RNAs that regulate gene function. The pathological roles of circRNAs in CAD have not, however, been comprehensively summarized. In this article, we review published research linking circRNAs to CAD and summarize the regulatory roles of circRNAs in the pathogenesis of coronary atherosclerosis, myocardial infarction, ischemia/reperfusion injury, and ischemic heart failure.
冠状动脉疾病(CAD)是一种由冠状动脉结构或功能异常引起的心脏疾病,可导致心肌缺血和缺氧。CAD是全球发病和死亡的主要原因。尽管目前有有效的药物治疗方法,但迫切需要找到CAD的新型分子治疗靶点。分子生物学技术的发展使得环状RNA(circRNAs)被识别为一类新型的非编码RNA,可调节基因功能。然而,circRNAs在CAD中的病理作用尚未得到全面总结。在本文中,我们回顾了已发表的将circRNAs与CAD相关联的研究,并总结了circRNAs在冠状动脉粥样硬化、心肌梗死、缺血/再灌注损伤和缺血性心力衰竭发病机制中的调节作用。